BR0212625A - peptìdeos derivados de caseìna e usos dos mesmos em terapia - Google Patents

peptìdeos derivados de caseìna e usos dos mesmos em terapia

Info

Publication number: BR0212625A
Authority: BR; Brazil
Prior art keywords: casein; derived; peptides; therapy; derived peptides
Prior art date: 2001-08-30

Application number

BRPI0212625-7A

Other languages

English (en)

Portuguese (pt)

Inventor

Zvi Sidelman

Original Assignee

Chay 13 Medical Res Group N V

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-30

Filing date

2002-08-29

Publication date

2007-06-19

2001-08-30 Priority claimed from US09/942,121 external-priority patent/US20020147144A1/en

2002-08-29 Application filed by Chay 13 Medical Res Group N V filed Critical Chay 13 Medical Res Group N V

2007-06-19 Publication of BR0212625A publication Critical patent/BR0212625A/pt

Links

239000005018 casein Substances 0.000 title abstract 4
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title abstract 4
235000021240 caseins Nutrition 0.000 title abstract 4
102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
238000002560 therapeutic procedure Methods 0.000 title abstract 2
230000004936 stimulating effect Effects 0.000 abstract 2
208000023661 Haematological disease Diseases 0.000 abstract 1
208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
230000011132 hemopoiesis Effects 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
235000013336 milk Nutrition 0.000 abstract 1
239000008267 milk Substances 0.000 abstract 1
210000004080 milk Anatomy 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
230000007170 pathology Effects 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Virology (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Zoology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
AIDS & HIV (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Emergency Medicine (AREA)
Marine Sciences & Fisheries (AREA)
Tropical Medicine & Parasitology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BRPI0212625-7A 2001-08-30 2002-08-29 peptìdeos derivados de caseìna e usos dos mesmos em terapia BR0212625A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/942,121 US20020147144A1 (en)	2000-03-01	2001-08-30	Casein derived peptides and uses thereof in therapy
PCT/IL2002/000720 WO2003018606A2 (en)	2001-08-30	2002-08-29	Casein derived peptides and uses thereof in therapy

Publications (1)

Publication Number	Publication Date
BR0212625A true BR0212625A (pt)	2007-06-19

Family

ID=25477603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0212625-7A BR0212625A (pt)	2001-08-30	2002-08-29	peptìdeos derivados de caseìna e usos dos mesmos em terapia

Country Status (15)

Country	Link
EP (1)	EP1556074A4 (cs)
JP (1)	JP2005511499A (cs)
KR (1)	KR20040078639A (cs)
CN (1)	CN1694719A (cs)
AU (1)	AU2002324323A2 (cs)
BR (1)	BR0212625A (cs)
CA (1)	CA2458924A1 (cs)
CZ (1)	CZ2004335A3 (cs)
HU (1)	HUP0500995A3 (cs)
IL (1)	IL160548A0 (cs)
MX (1)	MXPA04001890A (cs)
NO (1)	NO20040880L (cs)
PL (1)	PL375113A1 (cs)
WO (1)	WO2003018606A2 (cs)
ZA (1)	ZA200401574B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0313892D0 (en) *	2003-06-16	2003-07-23	Hannah Res Inst	Control of lactation
US20050192312A1 (en) *	2004-01-30	2005-09-01	Brown Dennis M.	Naphthalimide dosing by N-acetyl transferase genotyping
KR20070007128A (ko) *	2004-03-01	2007-01-12	펩테라 파마슈티컬스 엘티디.	카제인 파생 펩타이드들과 그의 치료적 사용들
GB0423352D0 (en) *	2004-10-21	2004-11-24	Hannah Res Inst	"Control of mammary cell number"
ES2319475B1 (es) *	2005-06-08	2010-02-16	Consejo Superior Investig. Cientificas	Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
EP2030629B1 (en) *	2006-06-09	2014-04-30	Morinaga Milk Industry Co., Ltd.	Alpha-s-casein as lipid-metabolism-improving agent
JP2011026213A (ja) *	2009-07-22	2011-02-10	Snow Brand Milk Prod Co Ltd	１型糖尿病抑制ペプチド
AU2013249522A1 (en) *	2012-04-16	2014-10-30	The Cleveland Clinic Foundation	Multivalent breast cancer vaccine
EP3590519A4 (en) *	2017-03-03	2020-12-16	Morinaga Milk Industry Co., Ltd.	GLP-1 SECRETAGOGUE AND COMPOSITION
CN107814835B (zh) *	2017-12-01	2020-04-28	熊猫乳品集团股份有限公司	一种生物活性多肽avpitptlnreq及其制备方法和应用
CN108017709B (zh) *	2017-12-12	2020-04-10	浙江辉肽生命健康科技有限公司	一种生物活性多肽kepmigvnqela及其制备方法和应用
CN113952446B (zh) *	2021-09-03	2023-12-05	河南省医药科学研究院	生物活性肽在抑制骨髓毒性中的应用
CN120815163B (zh) *	2025-09-16	2025-12-12	华中科技大学同济医学院附属同济医院	能抑制ccnb2表达的抗肿瘤药物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3778426A (en) *	1970-12-16	1973-12-11	Research Corp	Therapeutically useful polypeptides
US6150547A (en) *	1997-03-21	2000-11-21	Snow Brand Milk Products Co., Ltd.	Iron-casein complex hydrolyzate and process for the production thereof
IL134830A0 (en) *	2000-03-01	2001-05-20	Chay 13 Medical Res Group N V	Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them

2002
- 2002-08-29 HU HU0500995A patent/HUP0500995A3/hu unknown
- 2002-08-29 AU AU2002324323A patent/AU2002324323A2/en not_active Abandoned
- 2002-08-29 KR KR10-2004-7002884A patent/KR20040078639A/ko not_active Withdrawn
- 2002-08-29 CZ CZ2004335A patent/CZ2004335A3/cs unknown
- 2002-08-29 CN CNA028216741A patent/CN1694719A/zh active Pending
- 2002-08-29 EP EP02758768A patent/EP1556074A4/en not_active Withdrawn
- 2002-08-29 BR BRPI0212625-7A patent/BR0212625A/pt not_active IP Right Cessation
- 2002-08-29 MX MXPA04001890A patent/MXPA04001890A/es not_active Application Discontinuation
- 2002-08-29 CA CA002458924A patent/CA2458924A1/en not_active Abandoned
- 2002-08-29 PL PL02375113A patent/PL375113A1/xx not_active Application Discontinuation
- 2002-08-29 IL IL16054802A patent/IL160548A0/xx unknown
- 2002-08-29 WO PCT/IL2002/000720 patent/WO2003018606A2/en not_active Ceased
- 2002-08-29 JP JP2003523265A patent/JP2005511499A/ja active Pending
2004
- 2004-02-26 ZA ZA200401574A patent/ZA200401574B/en unknown
- 2004-02-27 NO NO20040880A patent/NO20040880L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1694719A (zh)	2005-11-09
CA2458924A1 (en)	2003-03-06
KR20040078639A (ko)	2004-09-10
CZ2004335A3 (cs)	2004-07-14
EP1556074A4 (en)	2008-05-07
EP1556074A2 (en)	2005-07-27
IL160548A0 (en)	2004-07-25
JP2005511499A (ja)	2005-04-28
MXPA04001890A (es)	2004-06-18
WO2003018606A9 (en)	2004-04-08
WO2003018606A3 (en)	2005-05-06
WO2003018606A2 (en)	2003-03-06
HUP0500995A3 (en)	2008-09-29
ZA200401574B (en)	2007-02-28
NO20040880L (no)	2004-04-20
HUP0500995A2 (en)	2007-05-02
AU2002324323A2 (en)	2003-03-10
PL375113A1 (en)	2005-11-28

Legal Events

Date	Code	Title	Description
2011-02-22	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A E 8A ANUIDADE(S).
2011-11-16	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2094 DE 22/02/2011.

Publication	Publication Date	Title
BR0109027A (pt)	2003-06-03	Peptìdios derivados de caseìna e usos dos mesmos em terapia
WO2005081628A3 (en)	2007-10-18	Casein derived peptides and therapeutic uses thereof
CA2158058A1 (en)	1994-09-15	Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
EP1005376A4 (en)	2004-11-24	METHODS AND COMPOSITIONS FOR USE IN GENE THERAPY FOR THE TREATMENT OF HEMOPHILIA
ATE476984T1 (de)	2010-08-15	Behandlung von herpes infektion mit anwendung von immunomodulatore polynukleotide sequenzen
CY1106152T1 (el)	2011-06-08	Νεα ανοσογονα αντι-hiv (ανατοξινες), μεθοδοι παρασκευης και εφαρμογη στην προληψη και στην αγωγη του aids
DE60024100D1 (de)	2005-12-22	Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
BR9808100A (pt)	2000-03-08	Utilização de amandantina para tratamento de hepatite c.
DK1429800T3 (da)	2009-04-27	Vaccine og anvendelse deraf til behandling af amyotrofisk lateral sklerose
KR20040078639A (ko)	2004-09-10	카세인 유도 펩타이드 및 이들의 치료 용도
FR2870126A1 (fr)	2005-11-18	Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin
BR112022024074A2 (pt)	2022-12-20	Coquetel de peptídeos
EP1222255A4 (en)	2004-03-31	POLYPEPTIDE FRAGMENTS COMPRISING A C-TERMINAL PART OF HELICOBACTER CATALASE
BR0113147A (pt)	2004-06-08	Proteìnas e peptìdeos do estresse e métodos de uso dos mesmos
EP1104310A4 (en)	2003-01-08	EXPRESSION AND CHARACTERIZATION OF AN HIV-1 CELL PROTEIN ASSOCIATED WITH A WIDE-REACTIVE NEUTRALIZING ANTIBODY RESPONSE.
ATE395064T1 (de)	2008-05-15	Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
EA200401390A1 (ru)	2005-02-24	N-ацетилглюкозамин-6-фосфатдеацетилаза человека, взаимодействующая с каспазой-8, и способы ее применения
IT1294967B1 (it)	1999-04-23	Composizione immunogenica da tlp
HUP9901299A2 (hu)	1999-07-28	Attenuált, nemimmunogén poxvírusokból vagy parapoxvírusokból előállított multipotens parapox immunitást előidéző gyógyszerek használatának új indikációi
ATE346091T1 (de)	2006-12-15	Neues diagnostisches reagens und kit zur erkennung von rickettsiose
IT1283899B1 (it)	1998-05-07	Peptidi e loro usi nella terapia della malattia celiaca
BG101846A (bg)	1998-07-31	Варианти на човешка дезоксирибонуклеаза i
ATE386542T1 (de)	2008-03-15	Mittel zur stimulation des immunsystems
JP2001172190A5 (cs)	2006-12-07
SE9703287D0 (sv)	1997-09-11	Peptides